|Subject Area||Medicine, Neuroscience, Pharmacology, Toxicology and Pharmaceutics|
|Subject Category||Medicine (miscellaneous), Neuroscience (miscellaneous), Pharmacology|
|Publisher||Bentham Science Publishers|
|Scope||CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal is devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics of CNS & neurological drug targets. These issues are organized and led by the guest editor who is a recognized expert in the overall topic. (source)|
Q1 (green) means highest values and Q4 (red) lowest values
The SJR indicator measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.
Evolution of Citations per Document to a journal's published documents during the two, three and four previous years. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.
Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Evolution of the number of total cites per document and external cites per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years.
International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country.
Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows.
Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.